Genetic variation in members of the leukotrienes biosynthesis pathway confers risk of ischemic stroke in Eastern Han Chinese

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 87, Issue 6, 2012, Pages 169-175

  Wang, Gannan ^a   Zhang, Jinsong ^a   Sun, Hao ^a   Cao, Weijuan ^a   Zhang, Jing ^a   Wang, Yao ^a   Xiao, Hang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetics; Ischemic stroke; Leukotrienes; Risk factors

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; LEUKOTRIENE; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE C4 SYNTHASE;

AGED; ALOX5 GENE; ALOX5AP GENE; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LTA4H GENE; LTC4S GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ARACHIDONATE 5-LIPOXYGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHINA; EPOXIDE HYDROLASES; FEMALE; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HETEROZYGOTE; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 84870676919     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.09.005     Document Type: Article

References (35)

1. Ding D., Lu C.Z., Fu J.H., Hong Z Predictors of vascular events after ischemic stroke: the China ischemic stroke registry study. Neuroepidemiology 2010, 34(2):110-116.
2. Matarin M., Singleton A., Hardy J., Meschia J. The genetics of ischaemic stroke. J. Intern. Med. 2010, 267(2):139-155.
3. Yamada Y., Ichihara S., Nishida T. Proinflammatory gene polymorphisms and ischemic stroke. Curr. Pharm. Des. 2008, 14(33):3590-3600.
4. Nakamura K., Nakagawa H., Sakurai M., et al. Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke: pooled analysis of 10 Japanese cohort studies. Cerebrovasc. Dis. 2012, 33(5):480-491.
5. Matarin M., Brown W.M., Dena H., et al. Candidate gene polymorphisms for ischemic stroke. Stroke 2009, 40(11):3436-3442.
6. Crosslin D.R., Shah S.H., Nelson S.C., et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum. Genet. 2009, 125(2):217-229.
7. Lindsberg P.J., Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34(10):2518-2532.
8. Hartiala J., Li D., Conti D.V., et al. Genetic contribution of the leukotriene pathway to coronary artery disease. Hum. Genet. 2011, 129(6):617-627.
9. Riccioni G., Bäck M., Capra V. Leukotrienes and atherosclerosis. Curr. Drug Targets 2010, 11(7):882-887.
10. Bäck M. Leukotriene signaling in atherosclerosis and ischemia. Cardiovasc. Drugs Ther. 2009, 23(1):41-48.
11. Liu L., Wu C., Wang Y., et al. Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 2011, 32(3):336-342.
12. Moore J.H. Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev. Mol. Diagn. 2004, 4(6):795-803.
13. Zintzaras E., Rodopoulou P., Sakellaridis N. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis. Am. J. Epidemiol. 2009, 169(5):523-532.
14. Kelly T.N., Gu D., Chen J., et al. Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 2008, 39(6):1688-1693.
15. Shen C.D., Zhang W.L., Sun K., Wang Y.B., Zhen Y.S., Hui R.T. Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese: a multicenter case-control study. Ann. Hum. Genet. 2007, 71(Pt 5):620-629.
16. Sun H., Wu H., Zhang J., et al. A tagging SNP in ALOX5AP and risk of stroke: a haplotype-based analysis among Eastern Chinese Han population. Mol. Biol. Rep. 2011, 38(7):4731-4738.
17. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 2004, 36(3):233-239.
18. Helgadottir A., Gretarsdottir S., Clair D., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am. J. Hum. Genet. 2005, 76(3):505-509.
19. Lõhmussaar E., Gschwendtner A., Mueller J.C., et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36(4):731-736.
20. Kaushal R., Pal P., Alwell K., et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum. Genet. 2007, 121(5):601-607.
21. Yamada Y., Kato K., Oguri M., et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int. J. Mol. Med. 2008, 21(6):801-808.
22. Bevan S., Dichgans M., Wiechmann H.E., Gschwendtner A., Meitinger T., Markus H.S. Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations. Stroke 2008, 39(4):1109-1114.
23. Domingues-Montanari S., Fernández-Cadenas I., del Rio-Espinola A., et al. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study. Cerebrovasc. Dis. 2010, 29(6):528-537.
24. Meschia J.F., Brott T.G., Brown R.D., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann. Neurol. 2005, 58(3):351-361.
25. Zee R.Y, Cheng S., Hegener H.H., Erlich H.A., Ridker P.M. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 2006, 37(8):2007-2011.
26. Lemaitre R.N., Rice K., Marciante K., et al. Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 2009, 204(2):e58-63.
27. Kostulas K., Gretarsdottir S., Kostulas V., et al. PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in Sweden. J. Neurol. Sci. 2007, 263(1-2):113-117.
28. Lövkvist H., Smith J.G., Luthman H., et al. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region. Eur. J. Hum. Genet. 2008, 16(9):1117-1125.
29. Quarta G., Stanzione R., Evangelista A., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians. Eur. J. Hum. Genet. 2009, 17(11):1448-1453.
30. Zhang W.L., Yang X.M., Shi J., Sun K., Hui R.T. Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao 2006, 33(8):678-684.
31. Ji R., Jia J., Ma X., Wu J., Zhang Y., Xu L. Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke. Cerebrovasc. Dis. 2011, 32(3):261-268.
32. Lee J.D., Lee T.H., Huang Y.C., et al. ALOX5AP genetic variants and risk of atherothrombotic stroke in the Taiwanese population. J. Clin. Neurosci. 2011, 18(12):1634-1638.
33. Helgadottir A., Manolescu A., Helgason A., et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet. 2006, 38(1):68-74.
34. Freiberg J.J., Tybjaerg-Hansen A., Sillesen H., Jensen G.B., Nordestgaard B.G. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 2008, 28(5):990-996.
35. Jawien J., Korbut R. The current view on the role of leukotrienes in atherogenesis. J. Physiol. Pharmacol. 2010, 61(6):647-650.